The AJMC® Pulmonary Arterial Hypertension compendium is a comprehensive resource for clinical news and expert insights for the progressive disorder, which is characterized by high blood pressure in the arteries that go from the heart to the lungs.
May 6th 2025
The 18-meter walk test (18MWT) effectively evaluates disease severity and predicts clinical outcomes in pulmonary arterial hypertension (PAH), enhancing traditional assessment methods.
Macitentan Safety, Effectiveness in PAH Confirmed in New Analysis
Potential Risk Factors Identified for RRT Among Patients With PH
Potential for Precision Medicine Approach in PAH Explored in New Study